Curran Simpson

(Mr. Curran Simpson)

Currently holds a position at Regenxbio Inc

Positions

Position Company Period
Senior Vice President - Product Development, Chief Technology Officer Regenxbio Inc Aug. 1, 2018 -
Senior Vice President - Technical Operations Regenxbio Inc Aug. 1, 2015 - Aug. 1, 2018
Senior Vice President - Operations Human Genome Sciences Inc Dec. 1, 2005 - July 30, 2012
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-05 2024-08-01
US Regenxbio Inc (RGNX)
PS Planned sale
100 -0.1%
15.00
USD 1,500 		100 -0.1% 15.00 USD 1,500
2024-07-30 2024-07-29
US Regenxbio Inc (RGNX)
PS Planned sale
9,648 -5.4%
15.04
USD 145,106 		9,648 -5.4% 15.04 USD 145,106
2021-01-14 2021-01-14
US Regenxbio Inc (RGNX)
PS Planned sale
11,612 -39.6%
50.01
USD 580,716 		11,612 -39.6% 50.01 USD 580,716
2021-01-14 2021-01-12
US Regenxbio Inc (RGNX)
PS Planned sale
1,700 -8.7%
50.03
USD 85,051 		1,700 -8.7% 50.03 USD 85,051
2021-01-11 2021-01-07
US Regenxbio Inc (RGNX)
PS Planned sale
5,185 -22.6%
50.01
USD 259,302 		5,185 -22.6% 50.01 USD 259,302
2020-02-12 2020-02-11
US Regenxbio Inc (RGNX)
PS Planned sale
3,692 -48.3%
51.37
USD 189,658 		3,692 -48.3% 51.37 USD 189,658
2020-02-12 2020-02-11
US Regenxbio Inc (RGNX)
PS Planned sale
8,872 -53.7%
50.13
USD 444,753 		8,872 -53.7% 50.13 USD 444,753
2020-02-12 2020-02-10
US Regenxbio Inc (RGNX)
PS Planned sale
44,429 -81.8%
50.22
USD 2,231,224 		44,429 -81.8% 50.22 USD 2,231,224
2020-02-07 2020-02-05
US Regenxbio Inc (RGNX)
PS Planned sale
5,637 -19.9%
50.00
USD 281,850 		5,637 -19.9% 50.00 USD 281,850
2020-01-21 2020-01-17
US Regenxbio Inc (RGNX)
PS Planned sale
5,922 -20.4%
50.00
USD 296,100 		5,922 -20.4% 50.00 USD 296,100
2019-05-30 2019-05-28
US Regenxbio Inc (RGNX)
PS Planned sale
18,000 -31.3%
50.00
USD 900,000 		18,000 -31.3% 50.00 USD 900,000
2019-02-27 2019-02-25
US Regenxbio Inc (RGNX)
PS Planned sale
5,300 -11.8%
54.05
USD 286,465 		5,300 -11.8% 54.05 USD 286,465
2019-02-07 2019-02-05
US Regenxbio Inc (RGNX)
PS Planned sale
43,832 -52.6%
50.08
USD 2,195,107 		43,832 -52.6% 50.08 USD 2,195,107
// ... existing code ... // ... rest of the file ...